Application research progress of single cell RNA-sequencing technology in neurodegenerative diseases
CSTR:
Author:
Affiliation:

1.Zigong Psychiatric Research Center Zigong Institute of Brain Science, Zigong 643020, China. 2. Department of Life Sciences and Medicine, Northwest University, Xi’an 710069

Clc Number:

R-33

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Neurodegenerative diseases (NDs) are closely related to the central nervous system and characterized by morphological abnormalities and progressive loss of function in specific neuron groups. The main NDs include Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis and Huntington’ s disease. However, no direct therapies for NDs exist. In recent years, single cell RNA-sequencing (scRNA-seq) has been widely used in various NDs. The pathogenesis of NDs is closely related to morphology of immune cells, and the pathogenesis mainly involves mitochondrial function, glucose metabolism, inflammation, and synaptic transmission. Induced pluripotent stem cells are a potential therapy for NDs. Ultimately, we review the application of scRNA-seq to various NDs and provide a reference for prevention and treatment of NDs.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 15,2023
  • Online: January 22,2024
Article QR Code